Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.tibtech.2012.11.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Views and opinions of the general public about the reimbursement of expensive medicines in the Netherlands.
PLoS One
January 2025
Department of Public Health, Healthcare Innovation & Evaluation and Medical Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Objectives: Solidarity-based healthcare systems are being challenged by the incremental costs of new and expensive medicines for cancer and rare diseases. To regulate reimbursement of such drugs, the Dutch government introduced a policy instrument known as the Coverage Lock (CL) in 2015. Little is known about the public opinion regarding such policy instruments and their consequences, i.
View Article and Find Full Text PDF"Unjustified Partiality or Impartial Bias? Reckoning with Age and Disability Discrimination in Cancer Clinical Trials".
J Law Med Ethics
December 2024
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CALIFORNIA, USA.
In this issue, Zakout discusses European Union (EU) legal provisions for inclusion of patients of all types in clinical trials. Shee highlights the unfortunate failure to include adequate numbers of older adults and adults with disabilities in clinical trials of anti-cancer agents. We agree with her argument that this is an ethical issue as well as a scientific and clinical issue.
View Article and Find Full Text PDFUnjustified Partiality or Impartial Bias? Reckoning with Age and Disability Discrimination in Cancer Clinical Trials.
J Law Med Ethics
December 2024
ERASMUS SCHOOL OF LAW, ROTTERDAM, THE NETHERLANDS.
The exclusion of the elderly and people with disabilities from cancer clinical research without appropriate justification is discriminatory and is at odds with the ethos of EU principles, laws and research regulations. It further limits study generalizability. Several primary EU laws fronted by the European Charter prohibit engaging in disparate impact discrimination on the grounds of age and disability in all of EU tasks.
View Article and Find Full Text PDFThe reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline.
Front Pharmacol
November 2024
Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Disproportionality analyses are the most-commonly used study design used in the post-marketing phase to detect suspected adverse drug reactions in individual case safety reports. Recent years have witnessed an exponential increase in published articles on disproportionality analyses, thanks to publicly accessible databases. Unfortunately, this trend was accompanied by concerns on lack of transparency and misinterpretation of results, both generating unjustified alarm and diluting true signals into overwhelming noise.
View Article and Find Full Text PDFHow Physician-Insurance Contracting Contributes to the Medical Exodus and Access to Ophthalmic Care in Puerto Rico.
Epidemiologia (Basel)
November 2024
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21202, USA.
Background: Puerto Rico (PR) has experienced significant demographic changes, characterized primarily by an aging population and an unprecedented exodus of medical doctors. Ophthalmologists are of particular concern as they commonly serve older populations, and the island has high rates of some age-related eye diseases in the United States (US). Our research aims to investigate the factors driving ophthalmologists in PR to emigrate to the mainland US.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!